DREAMseq: A phase III trial of treatment sequences in BRAFV600-mutant (m) metastatic melanoma (MM)—Final clinical results.
Year: 2025
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Michael B. Atkins, Sandra J. Lee, Bartosz Chmielowski, Ahmad A. Tarhini, Gary Irvin Cohen, Geoffrey Thomas Gibney, Thach-Giao Truong, Diwakar Davar, Joe Stephenson, Brendan D. Curti, Joanna M. Brell, Kari Lynn Kendra, Alexandra Ikeguchi, Zihe Song, Samantha Guild, Jedd D. Wolchok, Antoni Ribas, John M. Kirkwood
Institutions: Georgetown University Medical Center, Georgetown Lombardi Comprehensive Cancer Center, Dana-Farber Cancer Institute, University of California, Los Angeles, UCLA Jonsson Comprehensive Cancer Center, Moffitt Cancer Center, Greater Baltimore Medical Center, Cleveland Clinic, UPMC Hillman Cancer Center, MetroHealth Medical Center, Case Western Reserve University, The Ohio State University, University of Oklahoma Medical Center, Weill Cornell Medicine
Language: English
Topic: Melanoma and MAPK Pathways
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4410816838